Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   
X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

RALGAPA1P1 (Ral GTPase activating protein catalytic alpha subunit 1 pseudogene 1)

Identity

Alias_namesGARNL2
GARNL2P
RALGAPA1P
GTPase activating RANGAP domain-like 2 pseudogene
GTPase activating Rap/RanGAP domain-like 2 pseudogene
Alias_symbol (synonym)DKFZp566D133
Other aliasbA235C23.1
HGNC (Hugo) RALGAPA1P1
LocusID (NCBI) 26134
Atlas_Id 78279
Location 9q31.2  [Link to chromosome band 9q31]
Location_base_pair Starts at 105519824 and ends at 105527316 bp from pter ( according to hg38-Dec_2013)
Fusion genes
(updated 2017)		Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)

Note

Non-annotated gene. Preliminary data : if you are an author
who wish to write a full paper/card on this gene, go to  How to contribute

DNA/RNA

 

External links

Nomenclature
HGNC (Hugo)RALGAPA1P1   23203
Cards
Entrez_Gene (NCBI)RALGAPA1P1  26134  Ral GTPase activating protein catalytic alpha subunit 1 pseudogene 1
AliasesGARNL2; GARNL2P; RALGAPA1P; bA235C23.1
GeneCards (Weizmann)RALGAPA1P1
Ensembl hg19 (Hinxton)ENSG00000229419 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000229419 [Gene_View]  ENSG00000229419 [Sequence]  chr9:105519824-105527316 [Contig_View]  RALGAPA1P1 [Vega]
ICGC DataPortalENSG00000229419
TCGA cBioPortalRALGAPA1P1
AceView (NCBI)RALGAPA1P1
Genatlas (Paris)RALGAPA1P1
WikiGenes26134
SOURCE (Princeton)RALGAPA1P1
Genetics Home Reference (NIH)RALGAPA1P1
Genomic and cartography
GoldenPath hg38 (UCSC)RALGAPA1P1  -     chr9:105519824-105527316 +  9q31.2   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)RALGAPA1P1  -     9q31.2   [Description]    (hg19-Feb_2009)
GoldenPathRALGAPA1P1 - 9q31.2 [CytoView hg19]  RALGAPA1P1 - 9q31.2 [CytoView hg38]
ImmunoBaseENSG00000229419
Mapping of homologs : NCBIRALGAPA1P1 [Mapview hg19]  RALGAPA1P1 [Mapview hg38]
Gene and transcription
Genbank (Entrez)AL050050
RefSeq transcript (Entrez)
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)RALGAPA1P1
Cluster EST : UnigeneHs.113150 [ NCBI ]
CGAP (NCI)Hs.113150
Alternative Splicing GalleryENSG00000229419
Gene ExpressionRALGAPA1P1 [ NCBI-GEO ]   RALGAPA1P1 [ EBI - ARRAY_EXPRESS ]   RALGAPA1P1 [ SEEK ]   RALGAPA1P1 [ MEM ]
Gene Expression Viewer (FireBrowse)RALGAPA1P1 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
BioGPS (Tissue expression)26134
GTEX Portal (Tissue expression)RALGAPA1P1
Human Protein AtlasENSG00000229419-RALGAPA1P1 [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
Domain families : Pfam (Sanger)
Domain families : Pfam (NCBI)
Conserved Domain (NCBI)RALGAPA1P1
DMDM Disease mutations26134
Blocks (Seattle)RALGAPA1P1
Human Protein Atlas [tissue]ENSG00000229419-RALGAPA1P1 [tissue]
Protein Interaction databases
FunCoupENSG00000229419
BioGRIDRALGAPA1P1
STRING (EMBL)RALGAPA1P1
ZODIACRALGAPA1P1
Ontologies - Pathways
Huge Navigator RALGAPA1P1 [HugePedia]
snp3D : Map Gene to Disease26134
BioCentury BCIQRALGAPA1P1
ClinGenRALGAPA1P1
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD26134
Chemical/Pharm GKB GenePA134933837
Clinical trialRALGAPA1P1
Miscellaneous
canSAR (ICR)RALGAPA1P1 (select the gene name)
DataMed IndexRALGAPA1P1
Probes
Litterature
PubMed1 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineRALGAPA1P1
EVEXRALGAPA1P1
GoPubMedRALGAPA1P1
iHOPRALGAPA1P1
Genes in titleautomatic search in PubMed
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Sep 3 16:02:45 CEST 2019
Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.